Through regulating the JAK2/STAT3/FOXM1 axis, in vivo tumor xenograft assays further demonstrated that knockdown of AGK inhibited tumor development and decreased resistance to paclitaxel. The gene discussed is FOXM1; the disease is neoplasm.